Distinct and separable roles for EZH2 in neurogenic astroglia

被引:56
|
作者
Hwang, William W. [1 ,2 ,3 ]
Salinas, Ryan D. [1 ,3 ]
Siu, Jason J. [1 ,2 ,3 ]
Kelley, Kevin W. [3 ,4 ]
Delgado, Ryan N. [1 ,3 ]
Paredes, Mercedes F. [1 ,3 ,5 ]
Alvarez-Buylla, Arturo [1 ,3 ]
Oldham, Michael C. [3 ,5 ]
Lim, Daniel A. [1 ,2 ,3 ]
机构
[1] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Vet Affairs Med Ctr, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA
[5] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA
来源
ELIFE | 2014年 / 3卷
基金
美国国家卫生研究院;
关键词
NEURAL STEM-CELLS; SUBVENTRICULAR ZONE; SELF-RENEWAL; GENE-EXPRESSION; OLFACTORY-BULB; GENOME BROWSER; HUMAN BRAIN; DIFFERENTIATION; PRC2; NEURONS;
D O I
10.7554/eLife.02439
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The epigenetic mechanisms that enable specialized astrocytes to retain neurogenic competence throughout adult life are still poorly understood. Here we show that astrocytes that serve as neural stem cells (NSCs) in the adult mouse subventricular zone (SVZ) express the histone methyltransferase EZH2. This Polycomb repressive factor is required for neurogenesis independent of its role in SVZ NSC proliferation, as Ink4a/Arf-deficiency in Ezh2-deleted SVZ NSCs rescues cell proliferation, but neurogenesis remains defective. Olig2 is a direct target of EZH2, and repression of this bHLH transcription factor is critical for neuronal differentiation. Furthermore, Ezh2 prevents the inappropriate activation of genes associated with non-SVZ neuronal subtypes. In the human brain, SVZ cells including local astroglia also express EZH2, correlating with postnatal neurogenesis. Thus, EZH2 is an epigenetic regulator that distinguishes neurogenic SVZ astrocytes, orchestrating distinct and separable aspects of adult stem cell biology, which has important implications for regenerative medicine and oncogenesis.
引用
收藏
页数:19
相关论文
共 50 条
  • [41] Hypoxia makes EZH2 inhibitor not easy-advances of crosstalk between HIF and EZH2
    Huang, Zhanya
    Tang, Yuanjun
    Zhang, Jianlin
    Huang, Jiaqi
    Cheng, Rui
    Guo, Yunyun
    Kleer, Celina G.
    Wang, Yuqing
    Xue, Lixiang
    LIFE METABOLISM, 2024, 3 (04):
  • [42] The role of EZH1 and EZH2 in development and cancer
    Lee, Soo Hyun
    Li, Yingying
    Kim, Hanbyeol
    Eum, Seounghyun
    Park, Kyumin
    Lee, Chul-Hwan
    BMB REPORTS, 2022, 55 (12) : 595 - 601
  • [43] Role of EZH2 in ovarian carcinogenesis
    Ali-Fehmi, R.
    Munkarah, A.
    Bryant, C. S.
    Shah, J. P.
    Kumar, S.
    Malone, J. M.
    Morris, R. T.
    Sood, A. K.
    GYNECOLOGIC ONCOLOGY, 2009, 112 (02) : S150 - S150
  • [44] Bypassing cellular senescence by EZh2
    Kamminga, LM
    Bystrykh, L
    Houwer, S
    Douma, J
    Weersing, E
    Dontje, B
    de Haan, G
    BLOOD, 2004, 104 (11) : 760A - 760A
  • [45] The role of EZH2 in tumour progression
    Chang, C-J
    Hung, M-C
    BRITISH JOURNAL OF CANCER, 2012, 106 (02) : 243 - 247
  • [46] The role of EZH2 in tumour progression
    C-J Chang
    M-C Hung
    British Journal of Cancer, 2012, 106 : 243 - 247
  • [47] Targeting EZH2 in cancer therapy
    Yamagishi, Makoto
    Uchimaru, Kaoru
    CURRENT OPINION IN ONCOLOGY, 2017, 29 (05) : 375 - 381
  • [48] EZH2 inhibitors in immunotherapy of melanoma
    Hersey, Peter
    Gallagher, Stuart
    Tiffen, Jessamy
    Shklovskaya, Elena
    Wilson, Stephen
    Filipp, Fabian
    CANCER RESEARCH, 2017, 77
  • [49] EZH2 in B lymphocyte commitment
    Jacobsen, Jennifer
    Kee, Barbara
    JOURNAL OF IMMUNOLOGY, 2015, 194
  • [50] EZH2 as a therapeutic target for glioma
    Faruck, Lukmanul Hakkim
    Day, Charles
    Bhattarai, Suraj
    Langfald, Alyssa
    Hinchcliffe, Edward
    Robinson, James
    CANCER RESEARCH, 2024, 84 (05)